arrow
R

Rachel S. Carling

synnovis analytics
H指数:13
被引数:588

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Transitioning from Laboratory-Developed Tests to a Single Commercial Reagent Kit in a National Newborn Screening Program: Impact on Analytical Performance and Harmonization

从实验室自建检测方法过渡到国家新生儿筛查项目中单一商业试剂包:对分析性能和标准化的影响

2026-06-090
OA
Consistency in the Assessment of Dried Blood Spot Specimen Size and Quality in U.K. Newborn Screening Laboratories

英国新生儿筛查实验室对干血斑样本大小和质量的评估一致性

2025-08-210
PRE
Simple steps to achieve harmonisation and standardisation of dried blood spot phenylalanine measurements and facilitate consistent management of patients with phenylketonuria

实现干血斑苯丙氨酸测量的协调和标准化并促进苯丙酮尿症患者一致管理的简单步骤

2025-02-041
PRE
Consistency in the Assessment of Dried Blood Spot Specimen Size and Quality in U.K. Newborn Screening Laboratories

英国新生儿筛查实验室干血斑标本大小和质量评估的一致性

2024-09-051
OAAI
Retrospective Review of Positive Newborn Screening Results for Isovaleric Acidemia and Development of a Strategy to Improve the Efficacy of Newborn Screening in the UK
2024-03-130
OAAI
Targeted ultra performance liquid chromatography tandem mass spectrometry procedures for the diagnosis of inborn errors of metabolism: validation through ERNDIM external quality assessment schemes

用于诊断先天性代谢错误的靶向超高效液相色谱串联质谱程序: 通过ERNDIM外部质量评估方案进行验证

2024-03-110
PRE
A high throughput immuno-affinity mass spectrometry method for detection and quantitation of SARS-CoV-2 nucleoprotein in human saliva and its comparison with RT-PCR, RT-LAMP, and lateral flow rapid antigen test
2024-01-234
OA
Incidental Detection of Classical Galactosemia through Newborn Screening for Phenylketonuria: A 10-Year Retrospective Audit to Determine the Efficacy of This Approach
2023-12-222
OAAI